Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Renaissance Capital Greenwich Fund (NY: IPOS)
21.50 USD  UNCHANGED
Streaming Delayed Price  /  Updated: 9:30 AM EDT, Jun 20, 2019  /  Add to My Watchlist      
View: Quote News
Fund Overview
Renaissance Capital Greenwich Fund
Sector
Exchange Traded NY
Net Assets 2.15M
Inception Date
Related Funds
Quote
Price 21.50
Volume 39
Last Trade Jun 20, 9:30am
Change (%)
+0.00 (0.00%)
Prev. Close 21.50
YTD %
+14.79%
Dividend Yield 0.98%
Performance
YTD
+2.77 (14.79%)
1 Month
+0.75 (3.64%)
3 Month
+0.18 (0.87%)
6 Month
+3.09 (16.78%)
1 Year
-1.44 (-6.28%)
Chart
Charting
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Slack going public in a red-hot IPO market, with a twist
Workplace messaging firm Slack is about to go public in a red-hot IPO market, but it's approach to going public--using a "direct listing"--is slightly different than an IPO. Read More
from CNBC.com News
Personalis IPO: What You Need To Know
Data analytics in the biotech realm comes in the form of genomic sequencing – the process of determining the complete DNA sequence ... Read More
from Benzinga
Top News
More News
Here's who will get rich from Slack's stock market debut
Slack's public market debut on Thursday will generate billions for venture firm Accel and healthy returns for Andreessen Horowitz and Social Capital Read More
from CNBC.com News
Slack Sets IPO Reference Point At $26 Per Share
The New York Stock Exchange said Wednesday afternoon Slack Technologies (NYSE: WORK) has set its IPO reference point at $26 per share. ... Read More
from Benzinga
Prevail Therapeutics IPO: What You Need To Know
Want to partake in the gene therapy revolution that is emerging as a new paradigm in drug development? Check out the upcoming IPO of ... Read More
from Benzinga
Is Patience Still A Virtue? Maybe Not, As Fed Strikes That Word, Hints At Future Cuts
The Fed is out of patience, but plans to hold steady for now. The market arguably got what it wanted from today’s Fed meeting ... Read More
from Benzinga
Dermavant IPO: What You Need To Know
A dermatology-focused biotech with a lucrative Phase 3 asset is set to price its IPO this week. The IPO Terms Dermavant Sciences ... Read More
from Benzinga
Stoke Therapeutics Opens Above IPO Price
Stoke Therapeutics, Inc. (NASDAQ: STOK) opened Wednesday morning at $27.21 per share. The company priced 7 million shares of common ... Read More
from Benzinga
Atreca IPO: What You Need To Know
Cancer biotechs are the hottest among drug development companies, given the lucrative market opportunity before them. One such company ... Read More
from Benzinga
The Daily Biotech Pulse: Positive Readouts From Adamas And Ironwood, Sesen Bio To Offer Shares, Stoke Therapeutics Debut
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks Hitting ... Read More
from Benzinga
Grocery Outlet Holding IPO: What You Need To Know
Even as brick-and mortar retailers continue to suffer due to changing consumer dynamics and a fluid economic environment, a franchised ... Read More
from Benzinga
Akero Therapeutics IPO: What You Need To Know
A slew of biotech issues hitthe Street this week. Here's a brief on one of them. The IPO Terms Akero Therapeutics, Inc, ... Read More
from Benzinga
Weak Debut For Ship Lessor CSSC Shipping On Hong Kong's Stock Exchange
Shipyard-affiliated leasing company CSSC (Hong Kong) Shipping debuted on the Hong Kong Stock Exchange (HKEX: 3877) yesterday morning at ... Read More
from Benzinga
United Technologies makes hybrid-electric plane push with 'Project 804'
The aerospace giant says the development will be "platform agnostic" allowing further development by the likes of both Boeing and Airbus. Read More
from CNBC.com News
Stoke Therapeutics IPO: What You Need To Know
Biotech stocks present an exciting investment opportunity, given the heady gains they can fetch if one places the right bet at the right ... Read More
from Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.